| abstract |
The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof, which has excellent LCAT activation and can be used as arteriosclerosis, arteriosclerotic heart disease, coronary heart disease (including heart failure, myocardial infarction, angina pectoris, cardiac ischemia, cardiovascular disorders and angioplasty restenosis), cerebrovascular disease (including stroke and cerebral infarction), peripheral vascular disease (including diabetic vascular complications), dyslipidemia A therapeutic or prophylactic agent for a disease, a low HDL cholesterolemia, or a kidney disease, particularly an active ingredient of an anti-arteriosclerosis agent. □ [wherein R is a substituted aryl group or a substituted heteroaryl group]. |